CeNeS Pharmaceuticals plc (AIM: CEN), the biopharmaceutical company developing a new generation of pain management products, announces interim results for the six months ended 30 June 2006. In a separate announcement made today, CeNeS gives a more detailed update on its lead product for post-operative pain, M6G.
